tiprankstipranks

Ken Bartizal Insider Profile

4 Followers
Ken Bartizal, CDO at Cidara Therapeutics, holds 61.38K shares in Cidara Therapeutics (Ticker: CDTX), holds 99.71K shares in Trius Therap (Ticker: TSRX).
tipranks
Ken Bartizal

Ken Bartizal
Cidara Therapeutics (CDTX)
CDO

Not Ranked
Ken Bartizal has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$143K
100.00%
A breakdown of Ken Bartizal's holdings

Insider Roles

Cidara Therapeutics
(CDTX)
CDO
Roles that Ken Bartizal holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Ken Bartizal

Ken Bartizal's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cidara Therapeutics
Apr 14, 2015
CDO
Uninformative Buy
$143.01K
TSRX
Trius Therap
Aug 02, 2010
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Ken Bartizal's performance on stock

Ken Bartizal insider profile FAQ

What is the percentage of profitable transactions made by Ken Bartizal?
The percentage of profitable transactions made by Ken Bartizal is ―.
    What is the average return per transaction made by Ken Bartizal?
    The average return per transaction made by Ken Bartizal is ―.
      What stocks does Ken Bartizal hold?
      Ken Bartizal holds: CDTX, TSRX stocks.
        What was Ken Bartizal’s latest transaction?
        Ken Bartizal latest transaction was an Uninformative Buy of ―.
          What was Ken Bartizal's most profitable transaction?
          Ken Bartizal’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Ken Bartizal's role in Cidara Therapeutics?
            Ken Bartizal's role in Cidara Therapeutics is CDO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.